There are new drugs for the treatment of Type2 Diabetes being produced now to make life simpler and most of all the treatment better. Some of the new drugs are of the oral type such as, Januvia, Tradjenta and Onglyza. These oral drugs are DPP-4 inhibitors that are used to protect the natural compound, GLP-1, that is found in the body. These drugs help to prevent GLP-1 from breaking down. This is very important because GLP-1 is what helps to lower glucose levels in the body. Then you have the new drugs that are injected into the body, Byetta and Victoza which are incretin mimetics or the GLP analogs. These are used to make the signaling system of the body raise insulin after your meals.
Another drug, Symilin(an injectable hormone) is used to lower blood sugar after your meals. In addition there are also combination drugs which are making a tremendous difference for those that suffer from diabetes. With one pill you will receive a DPP-4 inhibitor, Metformin, a Sulfonylurea, Meglitinide or a combination of Thiazolidinedione and Sulfonylurea. With these combinations of medications into one pill you tremendously cut down the number of pills a person with diabetes has to take on any given day. There are other combinations such as, Avandamet, Actoplus MET, Duetact, Metaglip, PrandiMet, and Glucovance. There is only one problem with these combination drugs and that is that they will cost you more than generic drugs. In addition they make it more difficult to see which drug is the best for you since you are taking these combinations it is impossible to tell which one of the combinations is the best for you. It makes it harder to adjust the dosage to take, because you will have to adjust the other drug also, thus making a fine tune dosage very difficult.
Instead of multiple injections there are new types of insulin that will make it that you will only require one injection a day, thus lowering your multiple injections of insulin after every meal.
Even with the advances that have been made, most people are still using the older drugs. However, even the older drugs have their problems such as, Avandia which has been restricted by the FDA since it has been linked to cardiovascular dangers. In addition the drug Actos has now been linked to an increase danger of bladder cancer.
These new drugs for the treatment of Type 2 Diabetes offer people the options they didn’t have 10 years ago.